Wall Street Numbers logo
Wall Street Numbers logo
Wall Street Numbers
BioMarin Pharmaceutical Inc. company logo
BioMarin Pharmaceutical Inc. logo

BioMarin Pharmaceutical Inc. (BMRN)

Summary

As of today, BMRN price is $56.49, up +3.10% on
BMRN price is currently -62.77% below its historical high of $151.75 set on
BMRN current market cap is $11B, down -19.94% year-over-year
BMRN current PE ratio is 31.71
BMRN current annual revenue is $3.24B, up +14.18% year-over-year
The next earnings release for BMRN is on

Profile

Company profile for BioMarin Pharmaceutical Inc. (BMRN)
MetricValue
Full NameBioMarin Pharmaceutical Inc.
TickerNASDAQ: BMRN
ExchangeNASDAQ
SectorHealthcare
IndustryBiotechnology
CountryUnited States
IPO
IndexesNot included
Websitebiomarin.com
Employees3,040

Key Metrics

BioMarin Pharmaceutical Inc. Key Details
MetricDateValue
Price$56.49
Price, 1D Change+3.10%
Market Cap$11B
-
PE Ratio31.71
Beta0.80
Revenue$3B
Revenue, 1Y Change+14.18%
EPS$1.80
EPS, 1Y Change-18.24%

Chart

Add series to chart(max: 6)
Series
SUGGESTED SERIES
BioMarin Pharmaceutical Inc. chart

Events

BioMarin Pharmaceutical Inc. Events
MetricDateValue
Next Earnings
Last Qtr. Earnings
Last Ann. Earnings
Last Ex-DividendN/AN/A
Next Ex-DividendN/AN/A
Last SplitN/AN/A
Next SplitN/AN/A
Last Ticker ChangeN/AN/A
Next Ticker ChangeN/AN/A

🔒 Log In To Unlock Full Data

Estimates

BMRN Estimates
MetricDateValue
EPS$1.80
EPS EstimateN/A$5.34
EPS Est. ChangeN/A+195.89%
Revenue$3.24B
Revenue EstimateN/A$3.83B
Revenue Est. ChangeN/A+18.25%
Current Price$56.49
Price Target-$94.00
Price Tgt. Change-+66.40%

🔒 Log In To Unlock Full Data

EPS

BMRN EPS reported versus estimate values
YearEstimateReportedSurprise / Exp.
$3.30$2.21-33.04%
$3.26$1.80-44.59%
$5.34N/A+195.89%
$6.73N/A+273.14%
BMRN EPS reported versus estimate values chart

Revenue

BMRN revenue reported versus estimate values chart
YearEstimateReportedSurprise / Exp.
$2.81B$2.84B+0.88%
$3.18B$3.24B+1.89%
$3.83BN/A+18.25%
$4.48BN/A+38.27%
BMRN revenue reported versus estimate values chart

🔒 Log In To Unlock Full Data

Performance

BMRN Performance
MetricDateValue
Price, 1Y-20.09%
Price, 3Y-41.91%
Market Cap, 1Y-19.94%
Market Cap, 3Y-40.51%
Revenue, 1Y+14.18%
Revenue, 3Y+58.33%
EPS, 1Y-18.24%
EPS, 3Y+140.88%

🔒 Log In To Unlock Full Data

Technical Indicators

BMRN Technical Indicators
MetricDateValue
Current Price$56.49
SMA 200$56.53
SMA 200 vs Price+0.07%
SMA 50$58.38
SMA 50 vs Price+3.35%
Beta0.80
ATR$1.81
14-Day RSI46.98
10-Day Volatility30.19%
1-Year Volatility35.73%

Dividends

BMRN Dividends
MetricDateValue
N/A-
UpcomingN/AN/A
-
-
$0.00
0.00%

🔒 Log In To Unlock Full Data

Income & Profitability

BMRN Income & Profitability
MetricDateValue
Revenue$3.24B
EPS$1.80
Gross Profit$2.48B
Gross Margin77.27%
Operating Profit$533.48M
Operating Margin27.52%
Net Income$348.90M
Net Margin10.76%
EBITDA$613.04M

🔒 Log In To Unlock Full Data

Financial Health

BMRN Financial Health
MetricDateValue
Debt To Equity0.10
5.21
3.50
-
6
5.51

Valuations

BMRN Valuations
MetricDateValue
PE Ratio31.71
3.35
1.78
11.03
N/A-

Balance Sheet

BMRN Balance Sheet
MetricDateValue
Book Value$6.09B
$1.56B
$7.59B
$3.95B
$1.51B
$759.03M
Total Debt$597.18M
$8.69M
$759.03M

Expenses

BMRN Expenses
MetricDateValue
$2.87B
$1.95B
$736.83M
$0.00
$79.56M
$0.00
$133.58M

Cash Flow

BMRN Cash Flow
MetricDateValue
$827.99M
-$414.24M
-$42.39M
Capex$110.98M
$717.02M

Recent analyst updates

BMRN Recent analyst updates
MetricDateValue
B of A Securities→
Barclays→
HC Wainwright & Co.→
Freedom Broker→
Canaccord Genuity→
HC Wainwright & Co.→
Guggenheim→
Bernstein→
Oppenheimer→
Wells Fargo→

Analyst sentiment

Sentiment over the past month
BMRN analyst sentiment distribution chart

Institutional ownership

Largest institutional holders by ownership percentage
BMRN institutional ownership distribution chart

Screeners with BMRN

FAQ

  • What is the ticker symbol for BioMarin Pharmaceutical Inc.?

    The ticker symbol for BioMarin Pharmaceutical Inc. is NASDAQ:BMRN

  • Does BioMarin Pharmaceutical Inc. pay dividends?

    No, BioMarin Pharmaceutical Inc. does not pay dividends

  • What sector is BioMarin Pharmaceutical Inc. in?

    BioMarin Pharmaceutical Inc. is in the Healthcare sector

  • What industry is BioMarin Pharmaceutical Inc. in?

    BioMarin Pharmaceutical Inc. is in the Biotechnology industry

  • What country is BioMarin Pharmaceutical Inc. based in?

    BioMarin Pharmaceutical Inc. is headquartered in United States

  • When did BioMarin Pharmaceutical Inc. go public?

    BioMarin Pharmaceutical Inc. initial public offering (IPO) was on July 26, 1999

  • Is BioMarin Pharmaceutical Inc. in the S&P 500?

    No, BioMarin Pharmaceutical Inc. is not included in the S&P 500 index

  • Is BioMarin Pharmaceutical Inc. in the NASDAQ 100?

    No, BioMarin Pharmaceutical Inc. is not included in the NASDAQ 100 index

  • Is BioMarin Pharmaceutical Inc. in the Dow Jones?

    No, BioMarin Pharmaceutical Inc. is not included in the Dow Jones index

  • When was BioMarin Pharmaceutical Inc. last earnings report?

    BioMarin Pharmaceutical Inc.'s most recent earnings report was on February 23, 2026

  • When does BioMarin Pharmaceutical Inc. report earnings?

    The next expected earnings date for BioMarin Pharmaceutical Inc. is April 30, 2026

Data Sources & References

  1. BMRN Official Website www.biomarin.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1048477/000104847726000004/0001048477-26-000004-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1048477/000104847726000004/0001048477-26-000004-index.htm
  4. BMRN Profile on Yahoo Finance finance.yahoo.com/quote/BMRN
  5. BMRN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/bmrn